Age related eye disease (AREDS)
The Age-Related Eye Disease Study (AREDS) is a major clinical trial sponsored by the National Eye Institute, one of the federal government's National Institutes of Health. The AREDS was designed to learn more about the natural history and risk factors of age-related macular degeneration (AMD) and cataract and to evaluate the effect of high doses of vitamin C, vitamin E, beta-carotene and zinc on the progression of AMD and cataract. Results from the AREDS showed that high levels of antioxidants and zinc significantly reduce the risk of advanced AMD and its associated vision loss. These same nutrients had no significant effect on the development or progression of cataract
Related Conference of Age related eye disease (AREDS)
9th International Conference & Expo on Euro Optometry and Vision Science
20th International Conference on Ophthalmology and Vision Science
Age related eye disease (AREDS) Conference Speakers
Recommended Sessions
- Age related eye disease (AREDS)
- Cataract
- Conjunctivitis:
- Cornea disorders and treatments
- Diabetic retinopathy
- Diagnostic & therapeutic instruments used in optometry and ophthalmology
- Dry eye & low vision
- Eye floaters:
- Eye tumours
- Glaucoma: A vision loss
- Macular degeneration
- Neuro ophthalmology
- Ocular oncology
- Ophthalmic genetics and gene therapy
- Ophthalmology
- Ophthalmology surgery
- Optical imaging and sensing:
- Paediatric ophthalmology
- Refractive errors in children
- Strabismus
- Uveitis
Related Journals
Are you interested in
- Advances in Glaucoma Treatment - OPTOMETRY MEET 2025 (UK)
- AI in Ophthalmology - OPTOMETRY MEET 2025 (UK)
- Artificial Intelligence and Deep Learning in Ophthalmology - Euro Optometry 2025 (Switzerland)
- Cataract: Vision Problem - Euro Optometry 2025 (Switzerland)
- Cornea Disorders and Treatments - Euro Optometry 2025 (Switzerland)
- Digital Eye Strain and Blue Light Exposure - OPTOMETRY MEET 2025 (UK)
- Dry Eye Disease Management - OPTOMETRY MEET 2025 (UK)
- Effect of Digital Screens on Eye - Euro Optometry 2025 (Switzerland)
- Gene Therapy for Ocular Diseases - OPTOMETRY MEET 2025 (UK)
- Geriatric Optometry - OPTOMETRY MEET 2025 (UK)
- Glaucoma - Euro Optometry 2025 (Switzerland)
- Innovations in Contact Lens Design - OPTOMETRY MEET 2025 (UK)
- Latest and Innovative Eye Research - Euro Optometry 2025 (Switzerland)
- Macular Degeneration - Euro Optometry 2025 (Switzerland)
- Myopia management - OPTOMETRY MEET 2025 (UK)
- Myopia Management - Euro Optometry 2025 (Switzerland)
- Nano Ophthalmology - Euro Optometry 2025 (Switzerland)
- Neuro-ophthalmology - Euro Optometry 2025 (Switzerland)
- Nutrition and Eye Health - OPTOMETRY MEET 2025 (UK)
- Ocular Diseases - Euro Optometry 2025 (Switzerland)
- Ocular Oncology - OPTOMETRY MEET 2025 (UK)
- Ophthalmic Lenses and Laser Treatment - Euro Optometry 2025 (Switzerland)
- Ophthalmology - OPTOMETRY MEET 2025 (UK)
- Ophthalmology Surgery - Euro Optometry 2025 (Switzerland)
- Optometry and Vision Science - Euro Optometry 2025 (Switzerland)
- Pediatric Ophthalmology - Euro Optometry 2025 (Switzerland)
- Pediatric optometry - OPTOMETRY MEET 2025 (UK)
- Refractive Errors and Disorders - Euro Optometry 2025 (Switzerland)
- Regenerative Medicine in Eye Care - OPTOMETRY MEET 2025 (UK)
- Retina & its Disorders - Euro Optometry 2025 (Switzerland)
- Retinal Imaging and Innovations - OPTOMETRY MEET 2025 (UK)
- Strabismus - Euro Optometry 2025 (Switzerland)
- Sustainability in Ophthalmology - OPTOMETRY MEET 2025 (UK)
- Uveitis - Euro Optometry 2025 (Switzerland)
- Vision rehabilitation - Euro Optometry 2025 (Switzerland)